<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21">
 <label>21.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Arendrup</surname>
    <given-names>MC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cuenca-Estrella</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lass-Flörl</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hope</surname>
    <given-names>WW</given-names>
   </name>
  </person-group>, 
  <collab>European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST)</collab>. 
  <year>2012</year>
  <article-title>EUCAST technical note on 
   <italic>Aspergillus</italic> and amphotericin B, itraconazole, and posaconazole
  </article-title>. 
  <source>Clin Microbiol Infect</source>
  <volume>18</volume>:
  <fpage>E248</fpage>–
  <lpage>E250</lpage>. doi:
  <pub-id pub-id-type="doi">10.1111/j.1469-0691.2012.03890.x</pub-id>.
  <pub-id pub-id-type="pmid">22540149</pub-id>
 </mixed-citation>
</ref>
